Last checked at 25 Jul 2014 15:08
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Eco Animal Share News (EAH)
EAH Share
Price
EAH Share
News
EAH Share
Chat
EAH Share
Trades8
EAH
Live RNS
EAH Share
Charts
EAH Level 2
Console
EAH Live
Share Price
EAH Broker
Ratings
EAH Directors
Deals
EAH Financial
Diary
EAH
Fundamentals
EAH Short
Positions
EAH
Media
Eco Animal Information
Share Price Information for Eco Animal (EAH)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
128.00
Bid:
126.00
Ask:
130.00
Change:
-2.00 (-1.54%)
Spread:
4.00 (3.175%)
Open:
130.00
High:
130.00
Low:
128.00
Prev. Close:
130.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.ECO Animal Health gets marketing authorisation for Aivlosin granules in Europe
Tue, 02nd Apr 2019 15:02
(Sharecast News) - ECO Animal Health announced on Tuesday that it has received a marketing authorisation from the European Medicines Agency (EMA) for the use of 'Aivlosin' 625 mg/g water soluble granules in breeding chickens.The AIM-traded firm said the approval would allow it to market Aivlosin 625 mg/g water soluble granules in Europe for the treatment and metaphylaxis of respiratory infections caused by mycoplasma gallisepticum in breeding chickens producing eggs, for hatching broiler stock and for replacement layers.It said Aivlosin, its patented antimicrobial, was used under veterinary prescription for the treatment of a variety of "economically important" respiratory and enteric diseases in poultry and pigs."The EU has five per cent of the world's layer and ten per cent of the world's broiler parent stock," said ECO Animal Health chief executive officer Marc Loomes."This marketing authorisation is very significant as it provides an opportunity to roll out the approval beyond the EU into the multi-million dollar large international poultry markets."This will enable ECO to capitalise on the considerable global potential for Aivlosin which offers a safe and highly effective medication for Mycoplasma infections in high value breeding birds."
More News
25 Jul 2014 05:11
24 Jul 2014 15:43
24 Jul 2014 05:08
23 Jul 2014 15:12
23 Jul 2014 05:39
22 Jul 2014 15:37
22 Jul 2014 15:14
22 Jul 2014 05:23
21 Jul 2014 15:16
25 Feb 2014 11:08
Eco Animal Health Gets Korean Marketing Authorisation For Aivlosin Mix
LONDON (Alliance News) - Eco Animal Health Group PLC said Tuesday that it had received marketing authorisation for Aivlosin 42.5 milligram per gram premix, its treatment for respiratory disease in swine, in Korea. Authorisation was granted by the Animal and Plant Quarantine Agency in Korea.
Read more3 Feb 2014 10:22
Eco Animal Health Gets Canadian Marketing Authorisation For Aivlosin
LONDON (Alliance News) - Eco Animal Health Group PLC said Monday that it had been granted marketing authorisation by the Veterinary Drugs Director of Health Canada for its in-feed pig medication Aivlosin 17% premix. The Aivlosin 17% premix will be marketed for the treatment of porcine proli
Read more27 Jan 2014 09:24
ECO Animal Health Gets New European Marketing Clearance For Aivlosin
LONDON (Alliance News) - ECO Animal Health Group PLC Monday said it has received a marketing authorization from the European Medicines Agency for the use of its Aivlosin 625 milogram per gram water soluble granules in turkeys. The authorization allows for the medication of drinking water wi
Read more10 Dec 2013 15:13
ECO Animal Health thrives on higher-margin approach
AIM-listed veterinary drug specialist ECO Animal Health enjoyed a strong first six months of the year, traditionally its weaker period. A robust drug pipeline and a strong start to the second half leaves company management optimistic about full year results. For the half-year to September 30th e
Read more27 Nov 2013 14:54
Energy Assets improves lending arrangements
Gas metering provider Energy Assets has secured a new bank funding facility and refinanced a portion of its existing debts. The FTSE Fledgling group has arranged a new £25m funding facility with Bank of Scotland with drawdowns at an interest rate of 2.95% above the London interbank rate (LIBOR) wh
Read more